ono-2952
Small moleculeexperimental
Clinical trial activity
5 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2011 (NCT01364441)
Timeline
Indications
Mechanism of action
- Translocator proteinANTAGONIST
Translocator protein antagonist
- Translocator proteinINHIBITOR
TSPO inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
COc1cc(Cl)ccc1[C@H]1c2[nH]c3cccc(F)c3c2C2(CC2)CN1C(C)=O- Mol. weight
- 398.87 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4297311 ↗
Also known as
- ono-2952
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01887002 | Phase 2 | Jun 1, 2013 | Ono Pharmaceuticals |
| NCT01844180 | Phase 2 | Apr 1, 2013 | Ono Pharmaceuticals |
| NCT01613703 | Phase 1 | Aug 1, 2012 | Ono Pharmaceuticals |
| NCT01489345 | Phase 1 | Dec 1, 2011 | Ono Pharmaceuticals |
| NCT01364441 | Phase 1 | May 1, 2011 | Ono Pharmaceuticals |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ono Pharmaceuticals | For profit | 5 | 5 | 2 | 2011 |
1 organizations
Page 1 / 1